We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the experti... CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells. Show more
NetworkNewsWire Editorial Coverage: The cannabinoid-based pharmaceutical market is rapidly expanding, driving increased demand for a reliable flow of high-purity cannabinoids. With a market thatโs...
Live at MJAC 2017 Saturday 2nd September - 4.05 PM on Streaming Stage F How venture capital and cryptocurrency are converging as the future of cannabis investing ...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0001 | 1.85185185185 | 0.0054 | 0.0077 | 0.0054 | 69165 | 0.0073692 | CS |
4 | -0.0045 | -45 | 0.01 | 0.01 | 0.0053 | 130959 | 0.00722378 | CS |
12 | -0.0055 | -50 | 0.011 | 0.0199 | 0.005 | 129400 | 0.0087231 | CS |
26 | -0.002 | -26.6666666667 | 0.0075 | 0.0199 | 0.005 | 93731 | 0.0080647 | CS |
52 | -0.0081 | -59.5588235294 | 0.0136 | 0.0199 | 0.005 | 178991 | 0.01079736 | CS |
156 | -0.1045 | -95 | 0.11 | 5.5 | 0.005 | 249128 | 0.03099751 | CS |
260 | -0.1894 | -97.1780400205 | 0.1949 | 5.5 | 0.005 | 264213 | 0.14671444 | CS |
Symbol | Price | Vol. |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | $ 0.0037 (-19.57%) | 219.48M |
GRLFGreen Leaf Innovations Inc (PK) | $ 0.0001 (-50.00%) | 183.01M |
NSAVNet Savings Link Inc (PK) | $ 0.00045 (-10.00%) | 153.16M |
TKMOTekumo Inc (PK) | $ 0.00025 (-16.67%) | 145.76M |
ASIIAccredited Solutions Inc (PK) | $ 0.0006 (20.00%) | 145.16M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions